Tag Archives: EU regulator ‘firmly convinced’ AstraZeneca jab benefits outweigh risks

THE HAGUE: The EU’s medicines regulator said on Tuesday it was “firmly convinced” the benefits of AstraZeneca’s jab outweigh potential risks, insisting there was no evidence linking the vaccine to blood clots after a host of nations suspended the shot over health fears. The suspensions have led to intense debate over whether it was prudent to put AstraZeneca inoculations on …

Read More »